Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Mycophenolate Mofetil: later-stage trial registry

1 of 1 indexed Mycophenolate Mofetil trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Mycophenolate Mofetil: 1 US clinical trial tracked, 1 recruiting.

Mycophenolate Mofetil is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 1 of these trials.

Enrollment posture brief

Registry condition mycophenolate-mofetil

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Mycophenolate Mofetil (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Mycophenolate Mofetil

Mycophenolate Mofetil lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mycophenolate Mofetil on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mycophenolate Mofetil is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Mayo Clinic 1 trials

Named interventions

Most-linked intervention names on Mycophenolate Mofetil records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mycophenolate Mofetil (MMF) Withdrawal Group Drug
1 trials
Mycophenolate Mofetil (MMF) Maintenance Group Drug
1 trials

US sites by state

Facility locations filed on Mycophenolate Mofetil trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mycophenolate Mofetil page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Mycophenolate Mofetil trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Mycophenolate Mofetil trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mycophenolate Mofetil condition card totals 1 registered trials; most-linked intervention Mycophenolate Mofetil (MMF) Withdrawal Group; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.